Yifeng Pharmacy Chain Co., Ltd. (603939.SS) Bundle
Step into the world of Yifeng Pharmacy Chain Co., Ltd., a powerhouse in Chinese healthcare retail that pairs a clear mission-to improve patient health outcomes through timely, cost‑effective quality products-with a bold vision to revolutionize patient experience across its expansive network of stores; today Yifeng operates more than 14,000 drugstores across ten provinces and municipalities, delivered revenue of approximately ¥24.06 billion in 2024 and maintained a market capitalization near ¥28.55 billion as of December 2025, while historically reporting about ¥10 billion in revenue in 2022; the company enforces rigorous quality controls with 95% of products meeting its benchmarks before reaching customers, has trained over 10,000 pharmacy staff in customer engagement, invested more than ¥200 million in community health initiatives in 2022 reaching roughly 1 million people, and embeds core values-customer first, results‑oriented, innovative efficiency, diligence & pragmatism, responsibility & cooperation, growth & care-into robust talent development, advanced logistics automation (AGVs, miniloads, cross‑belt sorters, electronic labeling, RF systems) and an ERP‑driven operating model that supports its award‑winning status and rapid digital and retail evolution
Yifeng Pharmacy Chain Co., Ltd. (603939.SS) - Intro
Overview Yifeng Pharmacy Chain Co., Ltd. (603939.SS) is a leading pharmaceutical retailer in China with a broad product mix and extensive retail footprint. Established in 2001, Yifeng has grown into one of the country's largest drugstore chains, operating a network of over 14,000 stores across multiple provinces and municipalities. The company reported revenue of approximately ¥24.06 billion in 2024 and maintained a strong market capitalization of about ¥28.55 billion as of December 2025, reflecting sustained operational performance and investor confidence.- Store footprint: >14,000 drugstores nationwide (urban centers and towns).
- Product categories: Western medicines, Chinese patent medicines, TCM herbal pieces, medical devices, health supplements, personal care, and daily health-related convenience items.
- Founded: 2001; rapid expansion through organic growth and targeted store openings.
- Digital & omnichannel: integrated e-commerce, digital health services, and in-store digital tools to drive customer engagement and efficiency.
| Metric | Value | Reference Year / Date |
|---|---|---|
| Number of stores | Over 14,000 | 2024-2025 |
| Revenue | ¥24.06 billion | 2024 |
| Market capitalization | ¥28.55 billion | December 2025 |
| Year founded | 2001 | - |
- Provide safe, accessible, and affordable healthcare products and services to communities across China.
- Operate an integrated retail platform that combines professional pharmacy care with convenient, comprehensive product offerings.
- Drive value for customers, employees, suppliers, and shareholders through service excellence and responsible growth.
- Be the most trusted community pharmacy brand in China, delivering health solutions that improve everyday wellness.
- Lead the convergence of offline retail and digital health services to create seamless patient journeys and personalized care.
- Expand access to traditional and modern therapies while promoting safe medication use and preventive health.
- Customer First - prioritize patient safety, product quality, and service convenience.
- Professionalism - uphold pharmacy expertise, compliance, and clinical guidance at store level.
- Integrity - transparent sourcing, regulatory adherence, and ethical business conduct.
- Innovation - embrace digital platforms, data-driven operations, and new retail formats.
- Community Orientation - strengthen local healthcare access and public health education.
- Store network optimization: maintain >14,000 retail outlets while improving store-level profitability through category mix and service upgrades.
- Omnichannel integration: scale e-commerce sales, mobile app services, and click-and-collect to capture shifting consumer behavior.
- Product and service mix expansion: grow higher-margin OTC, health supplements, and wellness services alongside prescription fulfillment.
- Operational efficiency: leverage supply chain scale and digital inventory management to control costs and reduce stock-outs.
- Regulatory & compliance focus: ensure controlled substances, prescription services, and TCM products meet evolving regulatory standards.
- E-commerce and mobile: integrated platforms for online ordering, delivery, and prescription services to complement physical stores.
- Telehealth and digital consultation: pilot and scale remote pharmacy consultations and medication management tools.
- Data analytics: customer segmentation, loyalty programs, and targeted health campaigns to increase basket size and repeat visits.
Yifeng Pharmacy Chain Co., Ltd. (603939.SS) - Overview
Yifeng Pharmacy Chain Co., Ltd. (603939.SS) positions itself as a healthcare-first retail pharmacy operator focused on improving patient health outcomes through accessible, affordable, and high-quality pharmaceutical and healthcare products delivered promptly.
- Mission: Improve patient health outcomes by delivering quality pharmaceutical and healthcare products in a timely and cost-effective manner.
- Customer commitment: Prioritize customer health through trained staff, personalized service, and product reliability.
- Operational excellence: Maintain stringent quality assurance, supply-chain audits, and timely distribution to minimize stockouts and ensure product integrity.
- Community engagement: Invest in public health initiatives and free screening programs to extend care beyond retail transactions.
| Metric | 2022 Value / Status |
|---|---|
| Reported Revenue | ¥10,000,000,000 (approx.) |
| Quality assurance pass rate | 95% of products meet high-quality benchmarks before reaching customers |
| Pharmacy staff trained in customer engagement | Over 10,000 staff members |
| Community health investment (cash & programs) | Over ¥200,000,000 |
| Individuals reached via free health screenings | Approximately 1,000,000 people |
Core strategic priorities derived from the mission and current metrics:
- Quality-first sourcing and supplier oversight supported by routine audits and inspections to sustain the 95% QA benchmark.
- Workforce capability building - ongoing training programs to expand the pool of clinically informed, customer-centered pharmacy staff (10,000+ trained).
- Scaling community health programs and screenings funded through significant annual investments (¥200M+ in 2022) to drive preventive care reach (≈1 million individuals).
- Cost-effective distribution and product mix management to support competitive pricing while preserving margins within a ~¥10B revenue base.
Key operational levers and measurable targets:
- Maintain or improve product QA pass rate above 95% through supplier audits and batch testing.
- Increase trained pharmacy staff by X% year-over-year to expand customer engagement capacity (baseline: 10,000 trained staff in 2022).
- Allocate a defined portion of operating cash flow to community programs to sustain screening reach at or above 1 million beneficiaries annually.
Further reading: Yifeng Pharmacy Chain Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money
Yifeng Pharmacy Chain Co., Ltd. (603939.SS) - Mission Statement
Yifeng Pharmacy Chain Co., Ltd. (603939.SS) commits to transforming retail healthcare through patient-centered services, accessible product offerings, and continual innovation. The company's mission centers on delivering high-quality pharmaceuticals and healthcare solutions at competitive prices while ensuring safe, reliable, and empathetic customer experiences across its extensive retail footprint.- Deliver superior patient experiences via professional pharmacy services, counseling, and aftercare.
- Ensure consistent access to high-quality medicines and health products through a broad store network.
- Drive affordability and value by optimizing supply chains and pricing strategies.
- Leverage technology to improve safety, traceability, and customer convenience.
Vision Statement
Yifeng's vision is to revolutionize healthcare and elevate patient outcomes by combining product quality, impeccable customer service, and accessible pricing. This vision is reflected in three strategic pillars:- Accessibility: Expand and optimize store presence to meet community healthcare needs.
- Quality & Compliance: Maintain strict adherence to China's pharmaceutical regulations and industry best practices.
- Innovation: Integrate advanced technologies to enhance operational efficiency and customer experience.
| Metric | Value |
|---|---|
| Listed Ticker | 603939.SS |
| Retail Footprint | Over 14,000 drugstores |
| Geographic Coverage | 10 provinces/municipalities (Hunan, Hubei, Shanghai, Jiangsu, Jiangxi, Zhejiang, Guangdong, Hebei, Beijing, Tianjin) |
| Core Strategic Focus | Patient experience, product quality, affordability, technology-enabled operations |
| Recognition | Multiple industry awards (Most Innovative Retail Pharmacy Chain in China; Top 10 Pharmacy Chains in the World; Best Pharmacy Chain in Asia) |
Core Values
- Patient First - prioritize safety, privacy, and clinical accuracy in every interaction.
- Integrity & Compliance - uphold regulatory requirements and ethical sourcing across the supply chain.
- Service Excellence - deliver timely, knowledgeable, and courteous service at store and digital touchpoints.
- Innovation & Efficiency - deploy digital systems and data-driven processes to reduce errors and improve speed.
- Community Commitment - support local public health initiatives and broaden access to essential medicines.
Technology & Operational Capabilities
- Integrated retail management systems to streamline inventory, dispensing, and pricing controls.
- Digital customer channels and e-prescription links to hospitals and clinics to improve continuity of care.
- Data analytics for demand forecasting and localized assortment, improving on-shelf availability across 14,000+ stores.
- Quality-control systems and traceability to ensure compliance with China's pharmaceutical safety standards.
For an investor-oriented perspective and deeper operational profile, see: Exploring Yifeng Pharmacy Chain Co., Ltd. Investor Profile: Who's Buying and Why?
Yifeng Pharmacy Chain Co., Ltd. (603939.SS) - Vision Statement
Yifeng Pharmacy Chain Co., Ltd. (603939.SS) grounds its corporate identity in a clear vision: to be China's most trusted community healthcare and pharmacy service platform, delivering accessible, safe, and high-quality pharmaceutical products and services through integrated retail, O2O, and supply-chain excellence. Core Values- Customer first - prioritize patient safety, medication accuracy, and service experience across all touchpoints.
- Results-oriented - link performance, accountability, and measurable outcomes to business and patient-health objectives.
- Innovative efficiency - deploy technology and process innovation to optimize cost, speed, and service reliability.
- Diligence & pragmatism - emphasize operational rigor, standardized protocols, and continuous improvement.
- Responsibility & cooperation - foster cross-functional teamwork, regulatory compliance, and social responsibility.
- Growth & care - invest in employee development, talent retention, and community health education.
- Training & assessment: Corporate culture is integrated into onboarding, annual talent assessments, and KPI scorecards, ensuring cultural alignment in promotions and rewards.
- Talent development system: A structured pathway combining workforce planning, periodic assessments, targeted training, mentorship, and transparent career ladders.
- Corporate university: A dedicated internal learning platform and multi-tiered training evaluation system drive mandatory participation, measurable learning outcomes, and managerial accountability.
- Warehouse automation: Implementation of automated conveyors, cross-belt sorters, Miniload replenishment, and AGV goods-to-person picking to accelerate throughput and reduce picking errors.
- Smart fulfillment: Electronic labeling, RF wireless picking/receiving, and smart consolidation/dispatch platforms enable smaller lead times and higher first-pass accuracy.
- Real-time visibility: Comprehensive visual monitoring and control systems provide end-to-end traceability across the cold chain and regulated medicines.
- ERP backbone: A unified ERP integrates HR, finance, materials, and information flows, improving inventory turns and administrative efficiency.
| Metric | Figure (approx.) | Period / Note |
|---|---|---|
| Number of retail stores | ~3,500+ | Company network across provinces (ongoing expansion) |
| Annual revenue | ~RMB 15.2 billion | Latest fiscal year (approx.) |
| Net profit | ~RMB 0.9 billion | Latest fiscal year (approx.) |
| Inventory turnover | ~8-10 turns/year | Post-ERP and logistics automation improvement |
| Warehouse automation rate | ~60-80% of core DC processes automated | Includes AGV, Miniload, sorting, and RF systems |
| Training hours per employee | ~30-60 hours/year | Corporate university and mandatory certifications |
| On-time fulfillment rate | >95% | Measured across central DC to stores and O2O orders |
- Performance management ties: KPIs link store sales, compliance rates, customer satisfaction scores, and training completion to compensation and promotion.
- Succession planning: Multi-level talent pools with rotational assignments and mentor programs to cultivate store managers, pharmacists, and logistics leaders.
- Employee engagement: Regular surveys, cultural immersion curricula, and leadership workshops administered via the corporate university to boost retention and execution.
- Service consistency: Standardized SOPs, electronic labeling, and RF-enabled picking reduce dispensing errors and enhance patient safety.
- Operational resilience: ERP-driven visibility and automated DCs enable faster response to demand surges and better inventory control, improving gross margin stability.
- Scalable growth: Talent pipelines and digitized processes allow faster store openings and integration of acquired chains while preserving culture and service quality.

Yifeng Pharmacy Chain Co., Ltd. (603939.SS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.